Hot Keywords
Ageing Neurodegenerative Diseases Neurodegeneration AD

Topic: Endocannabinoid System and Brain Diseases

A special issue of Ageing and Neurodegenerative Diseases

ISSN 2769-5301 (Online)

Submission deadline: 31 Mar 2023

Guest Editor(s)

  • Prof. Beisha Tang

    Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.

    Website | E-mail

  • Prof. Huaibin Cai

    Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.

    Website | E-mail

Special Issue Introduction

The endocannabinoid system, comprising endocannabinoids, cannabinoid receptors, and synthetic and metabolizing enzymes, is crucial for many physiological and pathological processes in the nervous system. During the past decades, studies have indicated that the endocannabinoid system is involved in the nervous system development, synaptic plasticity, neuroinflammation, neurodegeneration, etc., and alterations in the endocannabinoid system are found in a variety of brain diseases, including Parkinson’s disease, Alzheimer disease, Huntington disease, stroke, epilepsy, multiple sclerosis, pain, and schizophrenia. However, the molecular mechanisms of endocannabinoid signaling in the brain still remain unclear, hence the need to fill this gap in order to develop clinically successful treatment strategies.

This special issue aims at expanding the current knowledge on the endocannabinoid system in the brain under physiological and pathological conditions. Research articles, reviews, and comments are all welcomed.


The endocannabinoid system, endocannabinoids, brain, brain diseases

Submission Deadline

31 Mar 2023

Submission Information

For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 31 Mar 2023
Contacts: Leila Wang, Assistant Editor,

Published Articles

© 2016-2023 OAE Publishing Inc., except certain content provided by third parties